University of Southern California Mann School of Pharmacy
Alan is a fourth-year PhD candidate in Dr. Paul Beringer’s lab at USC Mann School of Pharmacy. His research focuses on investigating the epidemiology, mechanisms, and therapeutic approaches for CFTR modulator-mediated drug-induced liver injury (DILI), contributing to the lab's overall goal of optimizing safety and efficacy of CFTR modulators and other CF treatments in clinical practice. Alan completed his undergraduate studies at USC as well, graduating with a Bachelor of Science in Human Biology, a minor in Science and Management of Biomedical Therapeutics (SMBT), and a specialization in Applied Analytics.
Friday, September 27, 2024
10:15 AM – 12:15 PM ET